Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mulder, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulder, G. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 695-698
© 2001 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Diabetic foot ulcers: old problems—new technologies

Gerit D. Mulder

Regional Burn Center Wound Clinic, University of California San Diego Medical Center, California, USA

Introduction

The association of diabetic foot ulcers with a high incidence of amputation, morbidity and mortality is well documented in the international literature including guidelines from the American Diabetes Association, the International Consensus Panel of Diabetic Ulcers, and the German literature on Diabetic Foot Syndrome [1–3]. The cost of care incurred by the diabetic with foot lesions is surpassed only by the total cost of medical problems related to the disease. A brief review of the pathophysiology of diabetic ulcers and an understanding of the difference between chronic wounds will facilitate decisions related to the use of new technologies, including recombinant growth factors. The following overview of new technology related to diabetic foot ulcer care will summarize relevant information related to acute versus chronic wounds, assist in defining a chronic wound, and provide concise guidelines on appropriate prescription of new technologies.

Acute vs chronic wound healing

The cellular mechanism of wound repair . . . [Full Text of this Article]

Definition of chronic wounds

Advanced technology for diabetic foot ulcers

Recombinant platelet derived growth factor—relevance to diabetic foot ulcers

Summary

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 INT J LOW EXTREM WOUNDSHome page
N. Papanas and E. Maltezos
Growth Factors in the Treatment of Diabetic Foot Ulcers: New Technologies, Any Promises?
International Journal of Lower Extremity Wounds, March 1, 2007; 6(1): 37 - 53.
[Abstract] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
S. M. Bauer, R. J. Bauer, and O. C. Velazquez
Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds
Vascular and Endovascular Surgery, July 1, 2005; 39(4): 293 - 306.
[Abstract] [PDF]